Home/Filings/4/0001235802-19-000066
4//SEC Filing

Verdoorn Todd A. 4

Accession 0001235802-19-000066

CIK 0001401040other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:54 PM ET

Size

5.9 KB

Accession

0001235802-19-000066

Insider Transaction Report

Form 4
Period: 2019-06-24
Verdoorn Todd A.
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-06-24+71,02571,025 total
    Exercise: $4.60Exp: 2029-06-23Common Shares (71,025 underlying)
Holdings
  • Voting Common Shares, no par value per share

    2,000
Footnotes (1)
  • [F1]Vests in eight nearly equal quarterly installments over two years.

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001759883

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:54 PM ET
Size
5.9 KB